Literature DB >> 15045036

The benefits of microarrays as tools for studying neuropsychiatric disorders.

Edna Grünblatt1.   

Abstract

DNA microarray technology is currently an area of great interest. These microarray or "gene chip" technologies, which arose out of the development of large-scale sequencing approaches, are now coming increasingly into use, generating a far greater volume of data than the data representing the sequences themselves. This technology is a powerful tool for the analysis of the organization and regulation of the brain in both diseased and healthy subjects. It can provide new insights into gene function, disease pathophysiology, disease classification and drug development. In this review, the basic theory of microarray technology and its analysis methods are presented, and technical problems are discussed. Additionally, some current results from microarray technology conducted in neuropsychiatry are presented. (c) 2004 Prous Science. All rights reserved.

Entities:  

Mesh:

Year:  2004        PMID: 15045036

Source DB:  PubMed          Journal:  Drugs Today (Barc)        ISSN: 1699-3993            Impact factor:   2.245


  4 in total

Review 1.  Proteomics of the human brain: sub-proteomes might hold the key to handle brain complexity.

Authors:  F Tribl; K Marcus; G Bringmann; H E Meyer; M Gerlach; P Riederer
Journal:  J Neural Transm (Vienna)       Date:  2006-07-13       Impact factor: 3.575

2.  Identification of targeted analyte clusters for studies of schizophrenia.

Authors:  Tammy M K Cheng; Yu-En Lu; Paul C Guest; Hassan Rahmoune; Laura W Harris; Lan Wang; Dan Ma; Victoria Stelzhammer; Yagnesh Umrania; Matt T Wayland; Pietro Lió; Sabine Bahn
Journal:  Mol Cell Proteomics       Date:  2009-12-10       Impact factor: 5.911

3.  Microarray analysis reveals distinct gene expression patterns in the mouse cortex following chronic neuroleptic and stimulant treatment: implications for body weight changes.

Authors:  C Mehler-Wex; E Grünblatt; S Zeiske; G Gille; D Rausch; A Warnke; M Gerlach
Journal:  J Neural Transm (Vienna)       Date:  2006-02-09       Impact factor: 3.575

Review 4.  Common transcriptional signatures in brain tissue from patients with HIV-associated neurocognitive disorders, Alzheimer's disease, and Multiple Sclerosis.

Authors:  Alejandra Borjabad; David J Volsky
Journal:  J Neuroimmune Pharmacol       Date:  2012-10-12       Impact factor: 4.147

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.